ABCF2 and hepatocellular carcinoma: ABCF2 is reported to be correlated with multidrug resistance; it inhibition is responsible for the antitumor role of miR‐122 in HCC (Yahya et al., 2018), suggesting that inhibition of ABCF2 might suppress cancer development.